What is topical dapsone and how is it used to treat acne vulgaris and other superficial skin conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Topical Dapsone?

Topical dapsone is a sulfone anti-inflammatory gel (available in 5% and 7.5% concentrations) FDA-approved for twice-daily treatment of acne vulgaris in patients ≥12 years of age, working primarily through anti-inflammatory mechanisms rather than antibacterial activity. 1

Mechanism of Action

  • Dapsone functions predominantly as an anti-inflammatory agent rather than through direct antibacterial killing of P. acnes 1
  • The drug inhibits production of reactive oxygen species, reduces eosinophil peroxidase effects on mast cells, and down-regulates neutrophil-mediated inflammatory responses 2
  • Its antibacterial properties stem from sulfonamide-like inhibition of dihydrofolic acid synthesis, though this is poorly studied for acne treatment 1, 2

Clinical Efficacy

  • In clinical trials, 35-42% of patients achieved treatment success using the Global Acne Assessment Score 1
  • Dapsone shows modest to moderate efficacy, primarily reducing inflammatory lesions more than comedonal lesions 1
  • The benefit in women significantly exceeds that in male and adolescent patients 1
  • Treatment response may be evident as early as 2 weeks for inflammatory lesions 3

Prescribing Information

Dosing

  • Apply approximately a pea-sized amount in a thin layer to acne-affected areas twice daily 1
  • The 7.5% gel formulation allows for once-daily application 3
  • Reassess treatment if no improvement occurs after 12 weeks 1

Patient Selection

  • Approved for patients ≥12 years of age 1
  • Particularly effective in female patients with inflammatory acne 1
  • Consider for patients with sensitive skin or darker skin types (Fitzpatrick IV-VI) due to benefits in post-inflammatory hyperpigmentation 4

Combination Therapy Considerations

  • Combine with topical retinoids when comedonal components are present, as dapsone alone has limited comedolytic activity 1
  • Critical drug interaction: Avoid co-application with benzoyl peroxide, which oxidizes dapsone causing orange-brown skin discoloration that can be washed off 1
  • Can be combined with oral isotretinoin, doxycycline, or topical retinoids when applied at different times 5, 6

Safety Profile

Common Adverse Effects

  • Local reactions include oiliness, peeling, dryness, erythema, burning, and pruritus 1
  • Systemic effects are rare but include nasopharyngitis, upper respiratory infections, headache 1
  • Serious but rare adverse effects: depression, psychosis, tonic-clonic movements, severe vomiting, pancreatitis 1

Important Safety Considerations

  • Glucose-6-phosphate dehydrogenase (G6PD) testing is NOT required before starting topical dapsone 1
  • However, some G6PD-deficient patients developed mild hemolysis changes; monitor for signs of hemolysis, peripheral neuropathy, and skin reactions 1
  • Pregnancy Category C 1
  • Dapsone is excreted in human milk; decide whether to discontinue nursing or discontinue the drug due to potential adverse reactions in nursing infants 1

Drug Interactions

Avoid or use caution with:

  • Trimethoprim/sulfamethoxazole 1
  • Topical benzoyl peroxide (causes skin discoloration) 1
  • Rifampin 1
  • Anticonvulsants 1
  • St. John's wort 1
  • Folic acid antagonists 1

Clinical Positioning

  • Use as an alternative topical agent for patients who fail or cannot tolerate first-line therapies (retinoids, benzoyl peroxide, topical antibiotics) 5
  • Not recommended as monotherapy for comedonal acne; requires combination with retinoids 1
  • Particularly valuable for female patients with predominantly inflammatory acne 1
  • The American Academy of Dermatology guidelines classify dapsone among topical therapies but note its mechanism is poorly understood compared to retinoids, which remain the cornerstone of topical acne treatment 1, 7

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Research

Update on the use of dapsone in dermatology.

International journal of dermatology, 2020

Research

Dapsone 7.5% Gel: A Review in Acne Vulgaris.

American journal of clinical dermatology, 2017

Research

Topical dapsone in the treatment of acne: a systematic review.

International journal of dermatology, 2022

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.